Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program

INTRODUCTION: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). This post hoc analysis assessed whether various statistical techniques could predict outcomes of tofacitinib maintenance therapy in patients with UC. METHODS: Data from patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiorean, Michael, Daperno, Marco, Lees, Charlie W., Bonfanti, Gianluca, Soudis, Dimitrios, Modesto, Irene, Deuring, J. Jasper, Edwards, Roger A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500009/
https://www.ncbi.nlm.nih.gov/pubmed/37525075
http://dx.doi.org/10.1007/s12325-023-02603-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500009/
https://www.ncbi.nlm.nih.gov/pubmed/37525075
http://dx.doi.org/10.1007/s12325-023-02603-0

Ejemplares similares